Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Tu T. Huynh, PhD
Contract Medical Writer for
Galderma Laboratories, LP
Fort Worth, TX
Contract Medical Writer for Galderma Laboratories, LP, Fort Worth, TX
Authored Items
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Tu T. Huynh, PhD
,
Matthew Mitchell, PharmD, MBA, FAMCP
July/August 2013 Vol 6, No 6
in
Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Tu T. Huynh, PhD
,
Matthew Mitchell, PharmD, MBA, FAMCP
Payer Perspectives in Dermatology
in
Dermatology
,
Original Research
Last modified: October 9, 2013